The short version
25 companies supply this market — deep enough that no single failure threatens the supply.
Market view
doxorubicin hydrochloride
86 marketed package NDCs · 25 active manufacturers
Most dispensed: 2 mg/mL · Injection, Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose · 2 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 100 ml in 1 vial, multi-dose · 2 mg/mL · Injection, Suspension, Liposomal · #1 vial, single-dose/carton / 10 ml in 1 vial, single-dose · 2 mg/mL · Injection, Solution · #1 vial, single-dose/carton / 10 ml in 1 vial, single-dose
Same drug class
Other molecules FDA puts in Anthracycline Topoisomerase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Doxorubicin hydrochloride in shortage right now?
- No. FDA does not currently list Doxorubicin hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Doxorubicin hydrochloride?
- 25 companies have marketed Doxorubicin hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.